We are live on ! Find out more
BG

BlackRock Group Portfolio holdings

AUM $210B
1-Year Est. Return 15.5%
This Fund
S&P 500
This Quarter Est. Return
+0.2%
1 Year Est. Return
+15.5%
3 Year Est. Return
+34.5%
5 Year Est. Return
10 Year Est. Return
AUM
$184B
AUM Growth
-$1.79B
Cap. Flow
-$1.11B
Cap. Flow %
-0.61%
Top 10 Hldgs %
14.47%
Holding
3,020
New
180
Increased
1,664
Reduced
865
Closed
95

Sector Composition

Rank Sector Weight
1 Healthcare 16.47%
2 Financials 14.48%
3 Technology 13.64%
4 Industrials 8.61%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SP
2401
DELISTED
SP Plus Corporation
SP
$324K ﹤0.01%
12,403
-22,780
-65% -$549K
IXYS
2402
DELISTED
IXYS Corp
IXYS
$323K ﹤0.01%
21,141
CEVA icon
2403
CEVA Inc
CEVA
$1.01B
$321K ﹤0.01%
16,520
+2,927
+22% +$59.9K
LQDT icon
2404
Liquidity Services
LQDT
$1.17B
$321K ﹤0.01%
33,277
+3,497
+12% +$34.4K
USCR
2405
DELISTED
U S Concrete, Inc.
USCR
$321K ﹤0.01%
8,493
+2,386
+39% +$88.9K
KERX
2406
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$321K ﹤0.01%
32,143
+6,601
+26% +$70.8K
ZAGG
2407
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$319K ﹤0.01%
40,302
-4,209
-9% -$37.7K
XCRA
2408
DELISTED
Xcerra Corporation
XCRA
$319K ﹤0.01%
42,142
+32,352
+330% +$290K
TUMI
2409
DELISTED
TUMI HLDGS INC COM
TUMI
$319K ﹤0.01%
15,532
+2,700
+21% +$59K
MHR
2410
DELISTED
MAGNUM HUNTER RESOURCES CORP (DEL)
MHR
$319K ﹤0.01%
170,179
-23,366
-12% -$46.3K
MGNX icon
2411
MacroGenics
MGNX
$235M
$317K ﹤0.01%
8,338
+5,816
+231% +$191K
SGMO
2412
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$316K ﹤0.01%
28,505
+3,175
+13% +$40.9K
RSYS
2413
DELISTED
Radisys Corp
RSYS
$316K ﹤0.01%
123,298
CULP icon
2414
Culp Inc
CULP
$45M
$315K ﹤0.01%
10,157
VRTV
2415
DELISTED
VERITIV CORPORATION
VRTV
$315K ﹤0.01%
8,631
+858
+11% +$34.9K
KYTH
2416
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$315K ﹤0.01%
4,180
+2,414
+137% +$129K
LDL
2417
DELISTED
Lydall, Inc.
LDL
$314K ﹤0.01%
10,625
+2,423
+30% +$70.1K
RBS.PRR
2418
DELISTED
Royal Bank of Scotland Group Plc (The) ADR repstg USD Pfd Sh
RBS.PRR
$313K ﹤0.01%
12,760
-2,086
-14% -$51.6K
MACK
2419
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$311K ﹤0.01%
3,197
-1,959
-38% -$186K
ONE
2420
DELISTED
HIGHER ONE HOLDINGS, INC COM STK
ONE
$310K ﹤0.01%
103,638
TRVN
2421
DELISTED
Trevena, Inc.
TRVN
$309K ﹤0.01%
79
+30
+61% +$127K
VVUS
2422
DELISTED
Vivus Inc
VVUS
$308K ﹤0.01%
13,058
+660
+5% +$16.2K
ARI
2423
Apollo Commercial Real Estate
ARI
$887M
$307K ﹤0.01%
18,669
+5,026
+37% +$86.3K
MYE icon
2424
Myers Industries
MYE
$1.18B
$306K ﹤0.01%
16,124
+3,683
+30% +$65K
MX icon
2425
Magnachip Semiconductor
MX
$128M
$305K ﹤0.01%
39,494
-16,731
-30% -$108K

Similar funds

BlackRock Group's Q2 2015 Portfolio in Review

As of Q2 2015, BlackRock Group held 3,020 positions worth $184B, down 0.97% from $186B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

BlackRock Group's Q2 2015 filing shows 180 new, 1,664 increased, 865 reduced and 95 closed positions. Its largest new stake was Jazz Pharmaceuticals: 396,108 shares worth $69.7M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $884M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

  • BlackRock Group's largest Q2 2015 buy was Jazz Pharmaceuticals: 396,108 shares worth $69.7M.
  • BlackRock Group added most to iShares MSCI Taiwan ETF in Q2 2015, an estimated $173M increase.
  • BlackRock Group's biggest Q2 2015 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $884M.
  • BlackRock Group fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $192M.
  • BlackRock Group's ten largest holdings make up 14% of its $184B portfolio in Q2 2015.
  • BlackRock Group opened 180 new positions and closed 95 in Q2 2015.
  • BlackRock Group's portfolio value fell 0.97% quarter-over-quarter to $184B.

Based on BlackRock Group's 13F filing for Q2 2015, filed 7 Aug 2015.